INC Research

INC Research strengthens leadership for strategic advisory services unit

Monday, December 10, 2012 01:44 PM

INC Research, a therapeutically focused CRO, has appointed Robert Ryan, PhD, as vice president of regulatory strategy, consulting and submissions. Ryan will provide global leadership to position INC Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

More... »

INC Research launches strategic advisory services unit

Wednesday, December 5, 2012 12:02 PM

INC Research, a therapeutically focused CRO, has launched INC Research Strategic Advisory Services, a new global business unit dedicated to providing biopharmaceutical customers with world-class consulting capabilities in the areas of drug development and commercialization, regulatory consulting and submissions and quality assurance.

More... »

INC Research expands in South Korea

Monday, September 17, 2012 09:27 AM

INC Research, a therapeutically focused CRO based in Raleigh, N.C., has opened a facility in Seoul, South Korea to manage the growing demand for world-class clinical development programs.

More... »

INC Research wins IACET accreditation for corporate training

Tuesday, August 28, 2012 12:26 PM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO, has been accredited as an authorized provider of the International Association of Continuing Education and Training (IACET), strengthening its corporate training programs. INC says it is the only global CRO authorized provider offering Continuing Education Units (CEUs) that qualify under the ANSI/IACET standard.

More... »

INC Research promotes Macdonald to CEO, Ogle to continue as chairman

Friday, August 17, 2012 07:42 AM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO has, as part of a planned succession, promoted Chief Operating Officer Jamie Macdonald to president and Chief Executive Officer. Chairman and CEO James T. Ogle will continue to serve as chairman.

More... »

INC Research selects TransPerfect’s Trial Interactive as eTMF solution

Thursday, May 17, 2012 09:18 AM

INC Research, a therapeutically focused CRO, has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution, according to TransPerfect, a provider of e-clinical technologies and creator of Trial Interactive. Trial Interactive is a secure, web-based platform that reduces the redundancies inherent in paper-based TMF management.

More... »

INC Research expands partnership with Medidata Solutions

Friday, May 11, 2012 11:32 AM

INC Research, a therapy-focused CRO, has broadened its services around Medidata Solutions' clinical cloud platform by attaining three new accreditations.

More... »

Report: INC Research to close clinical unit in W. Virginia

Thursday, April 26, 2012 03:01 PM

INC Research of Raleigh, N.C., confirmed it is closing its clinical study unit in Morgantown, W.V., according to an online report in The State Journal.

More... »

INC Research, Astellas form multi-year development alliance

Wednesday, April 18, 2012 11:04 AM

INC Research, a therapeutically focused CRO, has entered into a Functional Service Provider (FSP) alliance with Astellas Pharma to drive global consistency, save time and reduce costs for multiple clinical development programs across several therapeutic areas.

More... »

INC Research appoints Gaenzle as general counsel

Wednesday, April 11, 2012 03:38 PM

INC Research, a therapeutically focused CRO of Raleigh, N.C., has appointed Christopher L. Gaenzle as its general counsel.  

More... »